GlassScriptPhysician profile
Philip M Batista
NPI 1811216419
$24,731.11
in general payments reported to CMS, 2019-2025
29 companies · $3,359 in 2025
The $3,359 reported for 2025 was more than what 79% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,707 · 2020: $1,374 · 2021: $2,210 · 2022: $8,281 · 2023: $3,230 · 2024: $3,570 · 2025: $3,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,515 · Travel and Lodging: $1,894 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,515.45 |
| Travel and Lodging | $1,893.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,417.06 | 2021-2025 | Endurant Iis, Valiant Captivia |
| Silk Road Medical, INC. | $3,809.79 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $1,400.82 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Inari Medical, INC. | $1,361.93 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $1,267.31 | 2019-2025 | Advance, Zenith Spiral-Z, Cook |
| Boston Scientific Corporation | $837.11 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Ranger, Eluvia |
| Davol INC. | $750.00 | 2025 | |
| Penumbra, INC. | $735.19 | 2021-2025 | Indigo System, Ruby Coil |
| Medtronic Vascular, INC. | $719.35 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $700.00 | 2020 | |
| Stryker Corporation | $612.89 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Endologix LLC | $542.53 | 2019-2025 | |
| Becton, Dickinson and Company | $400.00 | 2021 | |
| Veryan Medical Incorporated | $189.86 | 2023-2024 | Biomimics 3d Vascular Stent System |
| Janssen Pharmaceuticals, INC | $185.68 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $166.13 | 2022-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Cvrx, INC. | $165.49 | 2024 | Barostim Neo System |
| Surmodics, INC. | $161.57 | 2022 | |
| Balt USA, LLC | $124.71 | 2022 | |
| Tactile Systems Technology INC | $32.13 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Terumo Medical Corporation | $22.73 | 2020 | |
| Exact Sciences Corporation | $21.71 | 2025 | Cologuard Collection Kit |
| Solventum Corporation | $19.18 | 2025 | Prevena, V.A.C.Ulta |
| Kci USA, INC. | $19.14 | 2020 | |
| Smith+Nephew, INC. | $19.11 | 2020 | |
| Merck Sharp & Dohme LLC | $16.98 | 2023 | Verquvo |
| Amgen INC. | $16.70 | 2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $16.01 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Batista listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.